Scripps Research is a nonprofit American medical research facility that focuses on research and education in the biomedical sciences. Headquartered in San Diego, California, the institute has over 170 laboratories employing 2,100 scientists, technicians, graduate students, and administrative and other staff. The institute holds over 1,100 patents, has produced 11 FDA-approved therapeutics, and has generated over 50 spin-off companies. The Scripps Research graduate program is ranked 1st nationally in the biological sciences, and 7th for chemistry. In 2022, their Jupiter, Florida, campus became a part of the University of Florida. Jupiter-based graduate students remain part of the Scripps Research graduate program.
History Scripps Research began with the Scripps Metabolic Clinic, founded near the current site in the La Jolla area of San Diego in 1924 by philanthropist Ellen Browning Scripps, who was inspired by the discovery of insulin. In 1946, the metabolic clinic separated from Scripps Memorial Hospital. In 1956, Scripps Research was renamed Scripps Clinic and Research Foundation to reflect its broader focus and management's renewed commitment to biomedical research. Harvard biochemist A. Baird Hastings joined the institute in 1959, followed by immunologist Frank J. Dixon and colleagues William Weigle, Joseph Feldman, Charles Cochrane, and Jacinto Vazquez in 1961, biochemist Frank Huennekens and microbiologist John Spizizen in 1962. Dixon was appointed director of research operations in 1974, and in 1977 these operations assumed the name of The Research Institute of Scripps Clinic. Upon Dixon's retirement in 1986, Richard Lerner, who had been chair of the Scripps Department of Molecular Biology, was appointed the research institute's new director. In 1989, the institute launched a graduate program. In 1991, as the result of a merger of hospitals, the research branch became part of a larger organization, the Scripps Institutions of Medicine and Science. In 1993, the research division separated from the clinical side, becoming an independent nonprofit organization under the name of the Scripps Research Institute (TSRI). An additional campus in Florida was instituted in 2004. Michael Marletta became president and CEO in 2012, assuming the position from Lerner. Marletta announced his resignation on July 21, 2014, and James C. Paulson was subsequently appointed acting president and CEO. In September 2015, Peter G. Schultz was appointed CEO, and Steve A. Kay, president. Kay announced he was returning to the University of Southern California in August 2016. In October 2016, TSRI announced a strategic affiliation with the non-profit California Institute for Biomedical Research (Calibr). The two organizations had already collaborated on several research programs in recent years, including the development of an antibody engineering platform aimed at improving treatments for chronic diseases such as diabetes and COPD, and immune therapies for the treatment of cancer. Calibr now represents the drug discovery and development division of Scripps Research. In February 2017, 5AM Ventures' John Diekman was named chairman of the board. In July 2018, TSRI was officially rebranded to Scripps Research. The Scripps Institution of Oceanography is often incorrectly associated with Scripps Research; it is in fact a nearby research facility that is part of UC San Diego. Scripps Research is a private nonprofit institute not directly associated with UCSD. Confusingly, the Scripps Institution of Oceanography was once called the Scripps Institution for Biological Research. In 2022, Scripps Florida separated from Scripps Research and became a part of the University of Florida.
Features Scripps Research's California campus is located on 35 acres (140,000 m2) of land between Torrey Pines State Natural Reserve and the University of California, San Diego, in La Jolla.
Departments and centers Scripps Research emphasizes interdisciplinary studies. Scripps Research scientists are organized into five interrelated departments: Chemistry, Immunology and Microbiology, Integrative Structural and Computational Biology, Molecular Medicine, and Neuroscience. The institute also incorporates the:
Center for Antiviral Medicines and Pandemic Preparedness Center for Metabolomics Center for Viral Systems Biology Dorris Neuroscience Center IAVI's Neutralizing Antibody Center at Scripps Research Scripps Research Alcohol Research Center The Scripps Research Translational Institute Scripps Research Digital Trials Center Skaggs Institute for Chemical Biology Skaggs Graduate School West African Research Network for Infectious Diseases (WARN-ID) Worm Institute for Research and Medicine
Notable people Among the 173 members of faculty are Nobel laureates Ardem Patapoutian, K. Barry Sharpless, and Kurt Wüthrich, as well as many other notable scientists, including Phil S. Baran, Donna Blackmond, Dale L. Boger, Benjamin Cravatt III, William R. Roush, Paul Schimmel, Peter G. Schultz, Gary Siuzdak, Eric Topol, Charles Weissmann, Ian Wilson, Peter Wright, Chi-Huey Wong and John R. Yates. In addition to the Nobel laureates, the Scripps Research faculty includes numerous members of the National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, National Academy of Engineering, American Association for the Advancement of Science and American Philosophical Society, as well as winners of the Wolf Prize in Chemistry and MacArthur Fellows Program ("genius grant"). The board of directors includes John D. Diekman (founder of 5AM Ventures), William R. Hearst III (chairman of the board, Hearst Corporation), Ge Li (founder of WuXi AppTec), and Joel S. Marcus (founder, Alexandria Real Estate Equities, Inc.).
Research rankings
… excerpt ends here. Continue reading the full article.



